Protalix BioTherapeutics - 22 Year Stock Price History | PLX

Historical daily share price chart and data for Protalix BioTherapeutics since 1998 adjusted for splits. The latest closing stock price for Protalix BioTherapeutics as of September 23, 2020 is 3.51.
  • The all-time high Protalix BioTherapeutics stock closing price was 875.00 on May 18, 1998.
  • The Protalix BioTherapeutics 52-week high stock price is 4.87, which is 38.7% above the current share price.
  • The Protalix BioTherapeutics 52-week low stock price is 1.70, which is 51.6% below the current share price.
  • The average Protalix BioTherapeutics stock price for the last 52 weeks is 3.18.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Protalix BioTherapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 3.4406 3.5600 4.6100 2.1000 3.5100 7.01%
2019 3.5303 3.4000 5.5000 1.7560 3.2800 5.47%
2018 5.1844 6.9390 7.5200 2.9450 3.1100 -52.96%
2017 7.8780 4.1530 14.4000 4.0500 6.6120 48.58%
2016 6.8047 10.1000 10.2000 2.8520 4.4500 -56.37%
2015 16.5446 18.7000 23.4000 7.8000 10.2000 -44.57%
2014 34.1525 39.6000 52.6000 18.0000 18.4000 -52.70%
2013 50.3766 54.0000 61.5000 37.2000 38.9000 -25.05%
2012 57.2596 50.0000 72.0000 48.0000 51.9000 5.27%
2011 64.8742 104.1000 104.6000 43.6000 49.3000 -50.60%
2010 75.6167 69.0000 100.0000 58.4000 99.8000 50.76%
2009 53.2214 18.5000 121.4000 18.0000 66.2000 259.78%
2008 25.4462 34.6000 37.0000 9.6000 18.4000 -45.88%
2007 229.9124 271.5000 457.2000 32.0000 34.0000 -79.64%
2006 378.3625 406.0000 539.0000 152.0000 167.0000 -60.71%
2005 47.9270 20.0000 511.0000 13.0000 425.0000 2025.00%
2004 25.6667 40.0000 40.0000 20.0000 20.0000 -50.00%
2003 21.0833 11.0000 51.0000 11.0000 40.0000 263.64%
2002 23.4921 23.0000 38.0000 11.0000 11.0000 -52.17%
2001 24.8557 19.0000 40.0000 15.0000 23.0000 22.99%
2000 32.0927 88.0000 94.0000 6.0000 18.7000 -78.63%
1999 95.3274 188.0000 263.0000 6.0000 87.5000 -61.11%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.117B $0.055B
Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx(R). Protalix's unique expression system presents a proprietary method for developing recombinant proteins in a cost-effective, industrial-scale manner. Protalix's first product manufactured by ProCellEx, taliglucerase alfa, was approved for marketing by the U.S. Food and Drug Administration (FDA) in May 2012 and, subsequently, by the regulatory authorities of other countries. Protalix has licensed to Pfizer Inc. the worldwide development and commercialization rights for taliglucerase alfa, excluding Brazil, where Protalix retains full rights.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.959B 15.74
Bristol Myers Squibb (BMY) United States $132.956B 10.24
CSL (CSLLY) Australia $94.659B 0.00
Gilead Sciences (GILD) United States $79.486B 11.44
Vertex Pharmaceuticals (VRTX) United States $69.696B 38.89
Regeneron Pharmaceuticals (REGN) United States $60.804B 23.25
Biogen (BIIB) United States $43.182B 7.39
Illumina (ILMN) United States $39.202B 45.59
Seattle Genetics (SGEN) United States $31.659B 0.00
Moderna (MRNA) United States $27.116B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.098B 10.46
Genmab (GMAB) Denmark $24.986B 15.78
BeiGene (BGNE) Cayman Islands $24.300B 0.00
Genmab (GNMSF) Denmark $23.331B 5.37
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $21.904B 0.00
Immunomedics (IMMU) United States $19.659B 0.00
Incyte (INCY) United States $19.012B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.137B 37.76
Alnylam Pharmaceuticals (ALNY) United States $15.498B 0.00
BioNTech SE (BNTX) Germany $15.171B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.077B 68.19
BioMarin Pharmaceutical (BMRN) United States $14.392B 104.42
Sarepta Therapeutics (SRPT) United States $11.486B 0.00
QIAGEN (QGEN) Netherlands $11.467B 29.10
ARGENX SE-ADR (ARGX) Netherlands $11.417B 0.00
Exact Sciences (EXAS) United States $10.950B 0.00
Guardant Health (GH) United States $10.705B 0.00
Bio-Techne Corp (TECH) United States $9.378B 64.35
Galapagos (GLPG) Belgium $8.968B 32.49
Exelixis (EXEL) United States $7.913B 28.77
SWEDISH ORP BIO (BIOVF) Sweden $7.814B 19.44
Ascendis Pharma (ASND) Denmark $7.624B 0.00
Repligen (RGEN) United States $7.558B 119.97
Mirati Therapeutics (MRTX) United States $7.295B 0.00
MyoKardia (MYOK) United States $7.029B 0.00
Novavax (NVAX) United States $6.840B 0.00
Acceleron Pharma (XLRN) United States $6.553B 0.00
Adaptive Biotechnologies (ADPT) United States $6.528B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.460B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.232B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.232B 193.07
Emergent Biosolutions (EBS) United States $5.332B 21.12
Ultragenyx Pharmaceutical (RARE) United States $5.017B 0.00
Blueprint Medicines (BPMC) United States $4.824B 0.00
Zai Lab (ZLAB) China $4.418B 0.00
China Biologic Products (CBPO) China $4.355B 25.85
MorphoSys AG (MOR) Germany $4.263B 55.86
Arena Pharmaceuticals (ARNA) United States $4.256B 0.00
Vir Biotechnology (VIR) United States $4.179B 0.00
NeoGenomics (NEO) United States $3.966B 1197.00
Denali Therapeutics (DNLI) United States $3.802B 0.00
Legend Biotech (LEGN) United States $3.773B 0.00
Reata Pharmaceuticals (RETA) United States $3.734B 0.00
Bluebird Bio (BLUE) United States $3.681B 0.00
Halozyme Therapeutics (HALO) United States $3.646B 0.00
Amicus Therapeutics (FOLD) United States $3.569B 0.00
Insmed (INSM) United States $3.369B 0.00
Principia Biopharma (PRNB) United States $3.321B 0.00
Global Blood Therapeutics (GBT) United States $3.287B 0.00
Fate Therapeutics (FATE) United States $3.221B 0.00
Twist Bioscience (TWST) United States $2.980B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.932B 0.00
Inovio Pharmaceuticals (INO) United States $2.845B 0.00
Alkermes (ALKS) Ireland $2.729B 57.20
Sorrento Therapeutics (SRNE) United States $2.609B 0.00
PHARMA MAR SA (PHMMF) Spain $2.290B 0.00
I-Mab (IMAB) China $2.254B 0.00
Mesoblast (MESO) Australia $2.128B 0.00
Editas Medicine (EDIT) United States $2.040B 0.00
Seres Therapeutics (MCRB) United States $2.020B 0.00
Zymeworks (ZYME) Canada $2.007B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.006B 22.47
Intra-Cellular Therapies (ITCI) United States $1.912B 0.00
Akcea Therapeutics (AKCA) United States $1.843B 0.00
Revance Therapeutics (RVNC) United States $1.809B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.801B 0.00
UniQure (QURE) Netherlands $1.780B 0.00
Eidos Therapeutics (EIDX) United States $1.743B 0.00
Amarin (AMRN) Ireland $1.484B 0.00
Sangamo Therapeutics (SGMO) United States $1.482B 0.00
Viela Bio (VIE) United States $1.475B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.465B 0.00
Cytokineticsorporated (CYTK) United States $1.451B 0.00
Ligand Pharmaceuticals (LGND) United States $1.440B 48.67
Beam Therapeutics (BEAM) United States $1.438B 0.00
Zealand Pharma (ZEAL) Denmark $1.433B 0.00
Mersana Therapeutics (MRSN) United States $1.427B 0.00
Coherus BioSciences (CHRS) United States $1.345B 7.84
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
Intellia Therapeutics (NTLA) United States $1.326B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.308B 0.00
Epizyme (EPZM) United States $1.285B 0.00
Arcus Biosciences (RCUS) United States $1.214B 0.00
Compugen (CGEN) Israel $1.208B 0.00
NGM Biopharmaceuticals (NGM) United States $1.152B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.133B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.091B 0.00
REGENXBIO (RGNX) United States $1.079B 0.00
Athenex (ATNX) United States $1.049B 0.00
Arvinas (ARVN) United States $1.027B 0.00
Castle Biosciences (CSTL) United States $1.012B 0.00
Alcobra (ARCT) United States $1.003B 0.00
Alector (ALEC) United States $0.985B 0.00
Adverum Biotechnologies (ADVM) United States $0.957B 0.00
Retrophin (RTRX) United States $0.953B 0.00
Myriad Genetics (MYGN) United States $0.946B 0.00
Heska (HSKA) United States $0.923B 0.00
Vericel (VCEL) United States $0.856B 0.00
NantKwest (NK) United States $0.836B 0.00
Pliant Therapeutics (PLRX) United States $0.834B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.832B 0.00
Morphic Holding (MORF) United States $0.819B 0.00
Cellectis S.A (CLLS) France $0.811B 0.00
Protagonist Therapeutics (PTGX) United States $0.780B 0.00
Agenus (AGEN) United States $0.776B 0.00
VBI Vaccines (VBIV) United States $0.758B 0.00
Frequency Therapeutics (FREQ) United States $0.756B 0.00
Kadmon Holdings (KDMN) United States $0.726B 0.00
Intrexon (PGEN) United States $0.715B 0.00
Pharming Group (PHGUF) Netherlands $0.714B 16.29
Codexis (CDXS) United States $0.708B 0.00
MiMedx (MDXG) United States $0.693B 0.00
Northwest Biotherapeutics (NWBO) United States $0.681B 0.00
Cara Therapeutics (CARA) United States $0.664B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
AC Immune SA (ACIU) Switzerland $0.626B 0.00
Clovis Oncology (CLVS) United States $0.614B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.598B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
WAVE Life Sciences (WVE) Singapore $0.577B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.565B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.564B 0.00
Geron (GERN) United States $0.559B 0.00
Scholar Rock Holding (SRRK) United States $0.540B 0.00
Albireo Pharma (ALBO) United States $0.540B 0.00
Dynavax Technologies (DVAX) United States $0.539B 0.00
Cel-Sci (CVM) United States $0.518B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.514B 4.50
IVERIC Bio (ISEE) United States $0.512B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.494B 0.00
Celldex Therapeutics (CLDX) United States $0.487B 0.00
Forte Biosciences (FBRX) United States $0.482B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.478B 0.00
Cue Biopharma (CUE) United States $0.477B 0.00
MeiraGTx Holdings (MGTX) United States $0.477B 0.00
Anika Therapeutics (ANIK) United States $0.474B 20.73
Kala Pharmaceuticals (KALA) United States $0.469B 0.00
Syros Pharmaceuticals (SYRS) United States $0.453B 0.00
MannKind (MNKD) United States $0.442B 0.00
Pfenex (PFNX) United States $0.441B 0.00
Starpharma Holdings (SPHRY) Australia $0.436B 0.00
AnaptysBio (ANAB) United States $0.430B 0.00
UROGEN PHARMA (URGN) United States $0.429B 0.00
Avid Bioservices (CDMO) United States $0.421B 0.00
Amryt Pharma (AMYT) United Kingdom $0.412B 0.00
Prothena (PRTA) Ireland $0.411B 0.00
Puma Biotechnology (PBYI) United States $0.404B 0.00
IBio (IBIO) United States $0.396B 0.00
Sutro Biopharma (STRO) United States $0.395B 0.00
BioDelivery Sciences (BDSI) United States $0.393B 27.79
Athersys (ATHX) United States $0.389B 0.00
Kamada (KMDA) Israel $0.387B 18.49
Xenon Pharmaceuticals (XENE) Canada $0.387B 0.00
Fortress Biotech (FBIO) United States $0.385B 0.00
Trevena (TRVN) United States $0.376B 0.00
Cellular Biomedicine (CBMG) United States $0.361B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.354B 0.00
PDL BioPharma (PDLI) United States $0.351B 0.00
ANI Pharmaceuticals (ANIP) United States $0.348B 8.22
Merus (MRUS) Netherlands $0.348B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.322B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.316B 0.00
CytomX Therapeutics (CTMX) United States $0.310B 0.00
Innate Pharma S.A (IPHA) France $0.295B 0.00
Precision BioSciences (DTIL) United States $0.285B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.283B 0.00
OSMOTICA PHARM (OSMT) United States $0.275B 0.00
Selecta Biosciences (SELB) United States $0.274B 0.00
Cardiff Oncology (CRDF) United States $0.272B 0.00
Cyclerion Therapeutics (CYCN) United States $0.269B 0.00
Prometic Life Sciences (LMNL) Canada $0.268B 0.00
Affimed (AFMD) Germany $0.267B 0.00
ChromaDex (CDXC) United States $0.261B 0.00
Arbutus Biopharma (ABUS) United States $0.251B 0.00
Pluristem Therapeutics (PSTI) Israel $0.248B 0.00
NextCure (NXTC) United States $0.244B 0.00
TELA Bio (TELA) United States $0.229B 0.00
Verastem (VSTM) United States $0.220B 0.00
Dyadic (DYAI) United States $0.210B 0.00
HOOKIPA Pharma (HOOK) United States $0.208B 0.00
Spero Therapeutics (SPRO) United States $0.206B 0.00
XOMA (XOMA) United States $0.204B 0.00
Aduro Biotech (ADRO) United States $0.204B 0.00
Liquidia Technologies (LQDA) United States $0.197B 0.00
DBV Technologies S.A (DBVT) France $0.196B 0.00
Kindred Biosciences (KIN) United States $0.194B 0.00
ADMA Biologics Inc (ADMA) United States $0.193B 0.00
Checkpoint Therapeutics (CKPT) United States $0.192B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Biofrontera AG (BFRA) Germany $0.186B 0.00
Cerecor (CERC) United States $0.185B 0.00
Theratechnologies (THTX) Canada $0.179B 0.00
Eton Pharmaceuticals (ETON) United States $0.179B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.174B 0.00
CorMedix Inc (CRMD) United States $0.169B 0.00
Exicure (XCUR) United States $0.167B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.165B 7.70
SESEN BIO, INC (SESN) United States $0.164B 0.00
Abeona Therapeutics (ABEO) United States $0.163B 0.00
Aptinyx (APTX) United States $0.161B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.157B 0.00
Aytu Bioscience (AYTU) United States $0.157B 0.00
AquaBounty Technologies (AQB) United States $0.150B 0.00
GENFIT S.A (GNFT) France $0.149B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.145B 0.00
Five Prime Therapeutics (FPRX) United States $0.141B 0.00
VolitionRX (VNRX) United States $0.141B 0.00
Bellus Health (BLU) Canada $0.138B 0.00
Applied Genetic Technologies (AGTC) United States $0.133B 0.00
VTv Therapeutics (VTVT) United States $0.133B 0.00
Cidara Therapeutics (CDTX) United States $0.131B 0.00
Celyad SA (CYAD) Belgium $0.129B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.124B 0.00
Strongbridge Biopharma (SBBP) United States $0.120B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.117B 0.00
Windtree Therapeutics (WINT) United States $0.117B 0.00
Palatin Technologies (PTN) United States $0.116B 2.99
Lumos Pharma (LUMO) United States $0.115B 0.00
Gritstone Oncology (GRTS) United States $0.111B 0.00
Orgenesis (ORGS) United States $0.111B 5.64
Enzo Biochem (ENZ) United States $0.109B 0.00
Unum Therapeutics (UMRX) United States $0.105B 0.00
Antibe Therapeutics (ATBPF) Canada $0.102B 0.00
PHASEBIO PHARMA (PHAS) United States $0.100B 0.00
Catalyst Biosciences (CBIO) United States $0.098B 0.00
ARAVIVE, INC (ARAV) United States $0.090B 0.00
Evogene (EVGN) Israel $0.089B 0.00
Bionano Genomics (BNGO) United States $0.089B 0.00
Oncobiologics (OTLK) United States $0.087B 0.00
Idera Pharmaceuticals (IDRA) United States $0.087B 0.00
AIT Therapeutics (XAIR) United States $0.087B 0.00
DiaMedica Therapeutics (DMAC) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Ecology Coatings (ABVC) United States $0.076B 0.00
Clearside Biomedical (CLSD) United States $0.074B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.072B 0.00
Prima BioMed (IMMP) Australia $0.071B 0.00
Edesa Biotech (EDSA) Canada $0.071B 0.00
Synlogic (SYBX) United States $0.070B 0.00
TRACON Pharmaceuticals (TCON) United States $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.064B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.062B 0.00
Curis (CRIS) United States $0.060B 0.00
Proteostasis Therapeutics (PTI) United States $0.060B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.059B 0.00
AmpliPhi Biosciences (ARMP) United States $0.058B 0.00
Soligenix (SNGX) United States $0.058B 0.00
Emmaus Life Sciences (EMMA) United States $0.057B 0.00
Cocrystal Pharma (COCP) United States $0.055B 0.00
AnPac Bio-Medical Science (ANPC) China $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.053B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
Stealth BioTherapeutics (MITO) United States $0.051B 72.50
Happiness Biotech Group (HAPP) China $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Novogen (KZIA) Australia $0.049B 0.00
Genetic Technologies (GENE) Australia $0.048B 0.00
CollPlant Holdings (CLGN) Israel $0.047B 0.00
Vaccinex (VCNX) United States $0.047B 0.00
Signal Genetics (MGEN) United States $0.046B 0.00
Organovo Holdings (ONVO) United States $0.045B 0.00
IMMURON (IMRN) Australia $0.044B 0.00
Pulmatrix (PULM) United States $0.040B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Chanticleer Holdings (SONN) United States $0.035B 0.00
Prana Biotechnology (ATHE) Australia $0.033B 0.00
BioCardia (BCDA) United States $0.031B 0.00
OvaScience (MLND) United States $0.031B 0.00
Advaxis (ADXS) United States $0.028B 0.00
Apricus Biosciences (SEEL) United States $0.028B 0.00
Cleveland BioLabs (CBLI) United States $0.027B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Celsion (CLSN) United States $0.026B 0.00
Acorda Therapeutics (ACOR) United States $0.025B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.024B 0.00
Cesca Therapeutics (THMO) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
Spherix (AIKI) United States $0.020B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
MYOS RENS Technology (MYOS) United States $0.017B 0.00
BioPharmX (TMBR) United States $0.011B 0.00
Neuralstem (SNCA) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00